An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts
- PMID: 1394152
An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts
Abstract
An analysis of trends in the incidence of non-Hodgkin's lymphoma requires an understanding of individual disease entities within this broad group. The non-Hodgkin's lymphomas represent a diverse group of malignancies that have in common an origin from lymphoid cells. Nevertheless, these disorders are heterogeneous in their clinical behavior, morphological appearance, cellular origin, etiology, and pathogenesis. A modern classification of non-Hodgkin's lymphomas must include an integration of morphological, immunophenotypical, and molecular concepts in order to delineate individual diseases within this broad group. Existing classification schemes such as the working formulation, while they may be useful in providing a guide to clinical management, cannot provide this information in the absence of other data. This point is most readily made with the low-grade B-cell lymphomas which include follicular lymphomas, mantle cell lymphomas, small lymphocytic lymphomas, immunosecretory disorders, and lymphomas of mucosa-associated lymphoid tissues. Each of these malignancies has a distinct phenotype and genotype, and indubitably each has a different etiology. The postthymic T-cell tumors are equally diverse. Analysis of epidemiological data from cancer registries must include a recognition that our ability to recognize individual diseases from historical data is limited. Studies of trends in the non-Hodgkin's lymphomas should attempt to delineate biological markers that may be of relevance to pathogenesis in both historical and prospectively accrued cases.
Similar articles
-
[R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].Praxis (Bern 1994). 1998 Jun 3;87(23):793-800. Praxis (Bern 1994). 1998. PMID: 9654985 German.
-
Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.Mod Pathol. 1996 Oct;9(10):959-65. Mod Pathol. 1996. PMID: 8902831
-
Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.Exp Hematol. 1994 Nov;22(12):1179-87. Exp Hematol. 1994. PMID: 7925781
-
[Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):276-82. Srp Arh Celok Lek. 1996. PMID: 9102863 Review. Serbian.
-
[Histopathology of malignant lymphomas].Rinsho Byori. 1990 Apr;38(4):386-9. Rinsho Byori. 1990. PMID: 2195192 Review. Japanese.
Cited by
-
Histamine content in lymph nodes from patients with malignant lymphomas.Inflamm Res. 1995 Apr;44 Suppl 1:S86-7. doi: 10.1007/BF01674409. Inflamm Res. 1995. PMID: 8521017 Clinical Trial. No abstract available.
-
p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations.Jpn J Cancer Res. 1996 Sep;87(9):930-7. doi: 10.1111/j.1349-7006.1996.tb02122.x. Jpn J Cancer Res. 1996. PMID: 8878455 Free PMC article.
-
Heterogeneity in B-cell neoplasms associated with rearrangement of the LAZ3 gene on chromosome band 3q27.Jpn J Cancer Res. 1994 Jun;85(6):592-600. doi: 10.1111/j.1349-7006.1994.tb02401.x. Jpn J Cancer Res. 1994. PMID: 8063612 Free PMC article.
-
Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.Jpn J Cancer Res. 1994 Dec;85(12):1270-9. doi: 10.1111/j.1349-7006.1994.tb02940.x. Jpn J Cancer Res. 1994. PMID: 7531681 Free PMC article.